Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Lipid Metabolism Disorders

• Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
• Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity
• EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
• Polypill in Acute Coronary Syndrome
• An Experimental Study on the Effect of Tenofovir Amibufenamide on Blood Lipid During Anti-HBV Treatment
• A Study of LY3561774 in Participants With Mixed Dyslipidemia
• Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes
• Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
• Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS)
• Vascepa to Accelerate Lipoprotein Uptake and Elimination
• Submental Study (Sequential Treatment Approach)
• Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran
• Fixed Combination for Lipid and Blood Pressure Control
• Impact of Liraglutide 3.0 on Body Fat Distribution
• Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers
• Effect of Carnitine on Uremic Cardiomyopathy
• A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques
• Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
• Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years
• Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
• A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers
• Regulation of Lipoprotein Transport in Metabolic Syndrome
• Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
• An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
• Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)
• Pharmacological Regulation of Fat Transport in Metabolic Syndrome
• Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
• Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
• Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration